{"resourceType":"Parameters","id":"ImmDS-2013-0202","parameter":[{"name":"assessmentDate","valueDate":"2020-06-29"},{"name":"patient","resource":{"resourceType":"Patient","id":"2013-0202","name":[{"family":"Dose 2 to dose 3 interval 8 wks-5 days. 4th dose needed.\nEvaluation_Test_Type: All Valid: Forecast Test\nGeneral_Description: This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 8 weeks - 5 days after dose #2, that the dose is considered valid, but a 4th dose is needed to complete the series."}],"gender":"female","birthDate":"2019-11-09","contact":[{"organization":{"reference":"Organization/FakeHospital"}}]}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0202-dose1","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"8","display":"RECOMBIVAX-PEDS"},{"system":"http://hl7.org/fhir/v2/0227","code":"MSD","display":"RECOMBIVAX-PEDS"}]},"patient":{"reference":"Patient/2013-0202"},"occurrenceDateTime":"2020-02-09T00:00:00.000"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0202-dose2","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"8","display":"RECOMBIVAX-PEDS"},{"system":"http://hl7.org/fhir/v2/0227","code":"MSD","display":"RECOMBIVAX-PEDS"}]},"patient":{"reference":"Patient/2013-0202"},"occurrenceDateTime":"2020-05-09T00:00:00.000"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0202-dose3","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"8","display":"RECOMBIVAX-PEDS"},{"system":"http://hl7.org/fhir/v2/0227","code":"MSD","display":"RECOMBIVAX-PEDS"}]},"patient":{"reference":"Patient/2013-0202"},"occurrenceDateTime":"2020-06-29T00:00:00.000"}}]}